UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Cardiac causes of cyanosis in the newborn

Author
Robert L Geggel, MD
Section Editors
Leonard E Weisman, MD
David R Fulton, MD
Deputy Editor
Carrie Armsby, MD, MPH

INTRODUCTION

For neonates with cyanotic congenital heart disease (CHD), early recognition, emergent stabilization, and transport to a cardiac care center with expertise in the management of cyanotic CHD are important to ensure an optimal outcome.

The causes of cyanotic CHD in the newborn are presented here. The presentation and screening of critical CHD and initial management of infants with cyanotic CHD are reviewed separately:

(See "Identifying newborns with critical congenital heart disease".)

(See "Newborn screening for critical congenital heart disease using pulse oximetry".)

(See "Diagnosis and initial management of cyanotic heart disease in the newborn".)

                      

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Wed Jun 08 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Lees MH. Cyanosis of the newborn infant. Recognition and clinical evaluation. J Pediatr 1970; 77:484.
  2. Marino BS, Bird GL, Wernovsky G. Diagnosis and management of the newborn with suspected congenital heart disease. Clin Perinatol 2001; 28:91.
  3. Nadas AS, Fyler DC. Hypoxemia. In: Nadas' Pediatric Cardiology, 2nd ed, Keane JF, Lock JE, and Fyler DC (Eds), Saunders Elsevier, Philadelphia 2006. p.97.
  4. Reller MD, Strickland MJ, Riehle-Colarusso T, et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 2008; 153:807.
  5. Khoshnood B, Lelong N, Houyel L, et al. Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study. Heart 2012; 98:1667.
  6. Ishikawa T, Iwashima S, Ohishi A, et al. Prevalence of congenital heart disease assessed by echocardiography in 2067 consecutive newborns. Acta Paediatr 2011; 100:e55.
  7. Wren C, Irving CA, Griffiths JA, et al. Mortality in infants with cardiovascular malformations. Eur J Pediatr 2012; 171:281.
  8. Liu S, Joseph KS, Lisonkova S, et al. Association between maternal chronic conditions and congenital heart defects: a population-based cohort study. Circulation 2013; 128:583.
  9. Ferencz C, Rubin JD, McCarter RJ, et al. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol 1985; 121:31.
  10. Wren C, Reinhardt Z, Khawaja K. Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Arch Dis Child Fetal Neonatal Ed 2008; 93:F33.
  11. Talner CN. Report of the New England Regional Infant Cardiac Program, by Donald C. Fyler, MD, Pediatrics, 1980;65(suppl):375-461. Pediatrics 1998; 102:258.
  12. Centers for Disease Control and Prevention (CDC). Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001. MMWR Morb Mortal Wkly Rep 2006; 54:1301.
  13. Duff DF, McNamara DG. History and physical examination of the cardiovascular system. In: The science and practice of pediatric cardiology, Garson A Jr, Bricker TM, Fisher DJ, Neish SR (Eds), Williams and Wilkins, Baltimore 1998. p.693.